SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
View HTML
NT 10-Q

Notification that form type 10-Q will be submitted late

Quarterly Filings
View HTML
25

Notification filed by National Securities Exchange to report the removal from listing and registration on a national securities exchange

Other
View HTML
25

Notification filed by National Securities Exchange to report the removal from listing and registration on a national securities exchange

Other
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe